Dr. Surendra Reddy Gulla is a cancer biologist specializing in prostate cancer, treatment resistance, and non-canonical AR and GR signaling. He is currently a Postdoctoral Associate at the State University of New York at Buffalo, focusing on translational research in advanced genitourinary cancers. A recipient of the AACR Scholar-in-Training Award from the Prostate Cancer Foundation (2025) , Dr. Gulla has extensive experience with CRISPR-Cas9, PDX models, and organoids. He earned his Ph.D. in Cancer Biology from Yogi Vemana University, India. His research has led to a strong publication record and presentations at major conferences, including the AACR Annual Meeting.